These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 372913)

  • 1. Luteinizing releasing factor and müllerian-inhibiting substance: a mistake?
    Josso N
    Pediatr Res; 1979 Feb; 13(2):142. PubMed ID: 372913
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadotropin control of müllerian-inhibiting substance.
    Bercu BB; Morikawa Y; Jackson IM; Donahoe PK
    Pediatr Res; 1979 Feb; 13(2):142. PubMed ID: 372912
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased secretion of Müllerian inhibiting substance after immunological blockade of endogenous luteinizing hormone releasing hormone in the rat.
    Bercu BB; Morikawa Y; Jackson IM; Donahoe PK
    Pediatr Res; 1978 Feb; 12(2):139-42. PubMed ID: 347363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone ontogeny in the ovine fetus. IX. Luteinizing hormone and follicle-stimulating hormone response to luteinizing hormone-releasing factor in mid- and late gestation and in the neonate.
    Mueller PL; Sklar CA; Gluckman PD; Kaplan SL; Grumbach MM
    Endocrinology; 1981 Mar; 108(3):881-6. PubMed ID: 6780326
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro synthesis of müllerian-inhibiting hormone by seminiferous tubules isolated from the calf fetal testis.
    Josso N
    Endocrinology; 1973 Oct; 93(4):829-34. PubMed ID: 4728217
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphorylation events during Müllerian duct regression.
    Hutson JM; Fallat ME; Kamagata S; Donahoe PK; Budzik GP
    Science; 1984 Feb; 223(4636):586-9. PubMed ID: 6607531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
    Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
    Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of the Müllerian-inhibiting activity of the human testis. Effect of fetal, peri-natal and post-natal human testicular tissue on the Müllerian duct of the fetal rat in organ culture.
    Josso N
    Biol Neonate; 1972; 20(5):368-79. PubMed ID: 4674819
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiandrogens and reproductive development.
    Neumann F; Elger W; Steinbeck H
    Philos Trans R Soc Lond B Biol Sci; 1970 Aug; 259(828):179-84. PubMed ID: 4399063
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of the testicular mullerian-inhibiting hormone on ovarian development in the chick embryo].
    Stoll R; Rashedi M; Maraud R
    C R Seances Soc Biol Fil; 1975; 169(4):927-30. PubMed ID: 129264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prenatal exposure to diethylstilbestrol on Müllerian duct development in fetal male mice.
    Visser JA; McLuskey A; Verhoef-Post M; Kramer P; Grootegoed JA; Themmen AP
    Endocrinology; 1998 Oct; 139(10):4244-51. PubMed ID: 9751506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular inhibition of fetal Mullerian ducts in vitro: effect of dibutyryl cyclic AMP.
    Picon R
    Mol Cell Endocrinol; 1975 Dec-1976 Jan; 4(1):35-42. PubMed ID: 173589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mullerian inhibiting substance: a fetal hormone with surgical implications.
    Hutson JM; Donahoe PK; Budzik GP
    Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone-releasing hormone suppression of human placental progesterone production.
    Wilson EA; Jawad MJ
    Fertil Steril; 1980 Jan; 33(1):91-3. PubMed ID: 6985876
    [No Abstract]   [Full Text] [Related]  

  • 15. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
    Wilson CA; di Clemente N; Ehrenfels C; Pepinsky RB; Josso N; Vigier B; Cate RL
    Mol Endocrinol; 1993 Feb; 7(2):247-57. PubMed ID: 8469238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regression of mullerian ducts in the female chick embryo treated by norethindrone and gonadotropins].
    Stoll R; Faucounau N
    C R Seances Soc Biol Fil; 1988; 182(6):579-83. PubMed ID: 2978015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pregnancy on the LH response to synthetic gonadotropin-releasing hormone in the ewe.
    Chamley WA; Findlay JK; Cumming IA; Buckmaster JM; Goding JR
    Endocrinology; 1974 Jan; 94(1):291-3. PubMed ID: 4587594
    [No Abstract]   [Full Text] [Related]  

  • 18. Local antifertility effect of luteinizing hormone-releasing hormone (LRH).
    Jones RC
    Contraception; 1979 Dec; 20(6):569-78. PubMed ID: 394915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory action of calf fetus testis on rat fetus Müllerian ducts in organotypic culture: role of seminiferous tubes].
    Josso N
    C R Acad Hebd Seances Acad Sci D; 1972 Jun; 274(26):3573-6. PubMed ID: 4630668
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of luteinizing hormone-releasing factor on human chorionic gonadotropin secretion.
    Khodr G; Siler-Khodr TM
    Fertil Steril; 1978 Sep; 30(3):301-4. PubMed ID: 361441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.